Showing results (31-40 of 201) with videos related to

Sort By:
Pageof 21
Current Oncology (Toronto, Ont.)|March 24, 2022
Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid CancerEtienne Gouton, Nausicaa Malissen, Nicolas André, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 12, 2024
A pilot quality improvement initiative for lymph node dissection during lung cancer surgeryPascal Alexandre Thomas, Cesare Braggio, Alex Fourdrain, et al.
Clinical Lung Cancer|November 17, 2018
Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung CancerMathieu Grangeon, Pascale Tomasini, Solene Chaleat, et al.
Anti-Cancer Drugs|January 26, 2011
Targeted therapies in malignant pleural mesothelioma: a review of clinical studiesLaurent Greillier, Sabine Marco, Fabrice Barlesi
Therapeutic Advances in Medical Oncology|February 17, 2018
Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapyFanny Jean, Pascale Tomasini, Fabrice Barlesi
Cancer Chemotherapy and Pharmacology|July 22, 2022
Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancerFabrice Barlesi, Laure Deyme, Diane-Charlotte Imbs, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2010
Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon?Ecaterina Ileana, Laurent Greillier, Vincent Moutardier, et al.
Oncotarget|May 20, 2017
Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patientsFabrice Barlesi, Diane-Charlotte Imbs, Pascale Tomasini, et al.
Interactive Cardiovascular and Thoracic Surgery|December 18, 2008
Redo medical thoracoscopy is feasible in patients with pleural diseases - a seriesDavid Breen, Anne Fraticelli, Laurent Greillier, et al.
Targeted Oncology|July 30, 2020
Antibody-Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and ChallengesSandrine Payan, Marc Montana, Christophe Curti, et al.
Pageof 21